Page 3 - Possible Value Trap News Today

Suresh Durgam, EVP, Chief Medical Officer of Intra-Cellular Therapies Inc (NASDAQ:ITCI), sold 6,167 shares of the company on February 2, 2024, according to a SEC Filing.

On February 1, 2024, Stephen Gordon, the CFO of TransMedics Group Inc (NASDAQ:TMDX), sold 15,000 shares of the company's stock.

On February 1, 2024, Karen Boone, a director at Peloton Interactive Inc (NASDAQ:PTON), executed a sale of 50,000 shares of the company, as reported in a recent SEC Filing.

Leonard Livschitz, the Chief Executive Officer of Grid Dynamics Holdings Inc (NASDAQ:GDYN), sold 15,000 shares of the company on January 30, 2024, according to a recent SEC filing.

Karin Walker, Chief Accounting Officer of Prothena Corp PLC (NASDAQ:PRTA), sold 5,000 shares of the company on January 24, 2024, according to a recent SEC Filing.

Director Allan Jacobson has sold 10,000 shares of PTC Therapeutics Inc (NASDAQ:PTCT) on January 22, 2024, according to a recent SEC Filing.

Chuck Royce (Trades, Portfolio)'s investment firm has recently increased its stake in Healthcare Services Group Inc (NASDAQ:HCSG), a notable move in the healthcare sector. Charles M. Royce, a venerated figure in small-cap investing, has been at the helm of Royce Pennsylvania Mutual Fund since 1972.

On January 16, 2024, Douglas Godshall, President & CEO of ShockWave Medical Inc (NASDAQ:SWAV), sold 10,000 shares of the company's stock, according to a recent SEC Filing.

Michael Halstead, EVP and General Counsel of Intra-Cellular Therapies Inc (NASDAQ:ITCI), has sold 50,000 shares of the company on January 11, 2024, according to a recent SEC Filing.

Jason Wudi, Chief Innovation Officer of Jamf Holding Corp (NASDAQ:JAMF), executed a sale of 15,000 shares in the company on January 10, 2024, according to a recent SEC Filing.